A total of 30 participants from India, Nepal, Nigeria, Sri Lanka, Thailand and the United States attended the webinar on March 20, 2017 to discuss Thailand's lessons learned in reaching the elimination of mother-to-child transmission (EMTCT) of HIV and syphilis. Thailand is the first country in the Asia and the Pacific region and the first with a large HIV epidemic to receive validation from the WHO for achieving this milestone.
The links to the presentation and summary are below:
A total of 105 participants from Uganda, Nepal, Iran, Zimbabwe, South Africa, Kenya, and many other countries attended the webinar on March 9th which featured new research on PMTCT and pediatric treatment presented at CROI 2017.
The links to the webinar, presentations, and webinar summary are below:
This governance guidance provides clarity, consistency and detail related to the structure, function, composition and operational duties of validation committees at national, regional and global levels as an extension to what is provided in the Global guidance on the criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis. In addition, this publication describes the standardized methods for country programme review and validation of EMTCT of HIV and syphilis and PTE at these levels.
This guidance document provides standardized processes and consensus-developed criteria to validate EMTCT of HIV and syphilis, and to recognize high-HIV burden countries that have made significant progress on the path to elimination. The guidance places strong emphasis on country-led accountability, rigorous analysis, intensive programme assessment and multilevel collaboration, including the involvement of communities of women living with HIV. It provides guidance to evaluate the country’s EMTCT programme, the quality and accuracy of its laboratory and data collection mechanisms, as well as its efforts to uphold human rights and equality of women living with HIV, and their involvement in decision-making processes.
In developing this revised document, WHO and the GVAC considered the input of national programmes, regional validation teams and committees, and experts in the areas of programme, data quality, laboratory standards, human rights, gender equality and community engagement. Topic areas that needed revision were also discussed during face-to-face meetings of the GVAC held in Geneva in June 2016 and June 2017.
These excel sheets provide outcome and impact, and coverage and output indicators. Outcomes and impacts require periodic review everyone to three years for the global fund supported programming. Impact and outcome assessments are to be based on all available information, including results of impact and outcome indicators as well as program reviews/evaluations and other assessments/studies.
The Prevalence and Incidence Calculator supports the estimation of HIV prevalence and incidence and provides full variance/covariance through analysis of cross-sectional surveillance data, including biomarkers, supporting classification of HIV cases as recently or non-recently acquired. The underlying logic in this calculator is core functionality of the R package inctools.